The question the unit holder is asking: "If the fund manager BREI is dismissed, what happens to CRVO and Olympus?"
Direct answer: no one knows, and that uncertainty is exactly the problem. The CRI CRVO represents 27,3% of the assets of the fund and is in judicial execution decreed in January 2026 — the BREI team conducts negotiation with the debtor and the procedural relationship. Changing managers in the middle of an execution does not press a "continue where you left off" button: there may be weeks or months of operational paralysis while the new house studies the case from scratch. On a credit of R$ 23 million in dispute, delay and loss of institutional knowledge can easily cost from R$ 5 to R$ 10 million to the fund. The 17,9% unit holder may be right about the fund manager being mediocre — and yet he is proposing the exchange at the worst possible time.
What is the IBCR11 And why the degay is so great
IBCR11 is a paper FII: instead of buying physical real estate, it buys CRIs (Certificates of Real Estate Receivables), which are debt securities backed in real estate receivables. In practice, the fund lends money to developers and logistics and receives IPCA interest + a fee. The IBCR11 portfolio today yields IPCA+9,77% per year on average, with duration of 6,45 years and without leverage (LTV of 0%).
The problem is that a significant part of these loans stopped paying. The unit is traded to R$ 49,00 against an equity value (VP) of R$ 89,22 — a 0,55 P/VP, i.e. a 41% defect. P/VP below 1 means that the market pays less than the portfolio is worth on paper. This huge discount is not generosity: it is the market that requires that part of the VP can never be recovered. The question of all IFI analysis of discounted paper is: is the disagency exaggerated (opportunity) or fair (real risk)? In the IBCR11, with two default CRIs and an ongoing governance fight, the answer is not obvious.
The core of the problem: the attempt to remove the BREI
In March 2026, a unit holder of 17,9% of units requested the convening of an AGE (Extraordinary General Assembly) with three requests: (1) remove the fund manager BREI and place the IGUANA INVESTMENTS In place; (2) extinguish the performance rate; and (3) transform the fund into a broad-term multi-strategy vehicle — i.e. no longer being a pure CRI FII to be able to invest in anything.
Why now? The unitholder's thesis is understandable: BREI delivered a TIR of -8% a year in unit since the IPO, two CRIs went into default under its management and the DPS dropped from R$ 1,50 (jan/22) to R$ 0,60. For a relevant holder, this is a history of destruction of value. Changing the fund manager, cutting the performance rate and opening the mandate is the classic recipe of an activist unit wanting to "unlock" a cheap fund.
IGUANA INVESTMENTS is a smaller fund manager, without the structured credit platform history that larger houses carry. Replacing BREI with a boutique in the middle of a complex judicial execution is not trivial: the continuity of the relationship with lawyers, with judgment and with debtors is an intangible asset that is not on the balance sheet, but that is worth real money when you are trying to execute a guarantee of R$ 33 millions.
BREI vehemently opposed, and her argument is not only self-preservation: she warns the risk of work discontinuity in recovery CRIs — CRVO and Olympus, which add up to more than one third of the PL. Here is the point that separates who is angry with the fund manager from who is thinking in the background: you can find the BREI bad and yet conclude that firing her now transfers control of a delicate operation to someone who will start from scratch. The cost of the learning curve, in an execution already decreed, comes out of the unit pocket.
Braspark: the good news (with an important exception)
It's not all a problem. In parallel, the CRI Braspark (5,8% of the PL, supported in a logistics shed in Garuva/SC) had its restructuring approved in AGE of March 2026. The design is ingenious: the debtor sells the logistical property to the FII GGRC11 and receives in exchange about R$ 200 million in shares from GGRC11 itself (integralization). Braspark then sells these shares in the secondary market and uses the cashier to pay off the CRI in 12 monthly instalments from August 2026.
The positive points are concrete: the rate was renegotiated for IPCA+9%+ZQ1ZQX prize, a new guarantee was created via fiduciary disposal of the shares GGRC11 (fiduciary disposal is when the creditor gets ownership of the asset in collateral until the debt is paid — here, covering 140% of the balance), and the term of the CRI shortens by about 4 years. For a fund that needs a cashier to relocate out of the troublesome CRIs, anticipating that recovery is great.
The exception is liquidity. Braspark can only sell a maximum of R$ 300 thousand GGRC11 units a day so as not to overturn the price. If he needs to convert, say, R$ 5 million into units, it's about 17 nails just to liquidate this slice — and this presupposes that the market will absorb the flow without sinking the GGRC11 unit. If the high school doesn't cooperate, the 12-month schedule slips. It is a good solution that depends on a variable that nobody controls: the appetite of the market.
The general picture: two defaults and a bottom reserve
Behind the governance struggle, portfolio health is what really matters. The CRI CRVO (27,3% of the PL, a BTS shed in the RS) had early maturity decreed in 23/01/2026 and is in execution of the fiduciary disposal of the property — whose report (R$ 33,4 mi) exceeds the debtor balance (R$ 23,2 mi), which gives security margin. While the execution runs, the lease of R$ 120 thousand/month continues to enter via fiduciary transfer, which mitigates the damage. The CRI Olympus (7,2% PL, a allotment in SP) has been in default since January 2025, with the unpaid bullet and negotiation still ongoing — also with collateral reports above the balance.
The fund's profit reserve has fallen to R$ 0,09/unit February 2026, historic minimum. That's important because the reserve is the mattress that supports the DPS when the cashier presses. With the reserve almost zeroed out, the R$ 0,60 DPS depends more and more on what effectively drips from the default CRIs — and any new hiccups overwhelm the distribution. Add to this the concentration: four CRIs of the Embedder Tarjab/Pateo group, all in Presidente Prudente/SP, add about 38% of the PL. It's a lot of risk in a single square and a single developer.
Stressed CRIs — Where Risk Lives
| CRI | % of PL | Situation |
|---|---|---|
| CRVO (BTS Unidaul/RS) | 27,3% | Early retirement Jan/26 — execution of AF (report R$ 33,4 mi > balance R$ 23,2 mi); rental R$ 120 thousand/month still flows |
| Pateo II + III (Tarjab/SP) | 25,6% | Renegotiated to IPCA+13% / 12,5% |
| Olympus (Looting/SP) | 7,2% | Default since Jan/25 — unpaid bullet, ongoing negotiation |
| Loft (Stock/SP) | 7,1% | Renegotiated — MTM to 1685% (extreme priced) |
| Braspark (Logistic/SC) | 5,8% | Approved restructuring — sale of the property to GGRC11, discharge 12x from Aug/26 |
| GDP (Joinville/SC) | 2,6% | Renegotiated |
To put the IBCR11 in the context of the sector: who seeks quality CRI with low default and unit close to the VP usually looks at names like KNCR11 (post-fixed, conservative). Already high-yield funds as HCTR11 and DEVA11 share with IBCR11 the same DNA: fat rates, large mismatches and portfolios with recovery credits. The IBCR11 is today a classic case of high-yield paper FII under stress — only with the extra layer of a command dispute.
Verdict: NEUTRO WITH HIGH RISK — keep those who already have, with an eye on the assembly; it is not entry for beginner
41% deage pays for the risk, but it's not free. With two default CRIs adding more than a third of the PL, historical minimum profit reserve and DPS already cut to R$ 0,60, the discount on the VP reflects real damage, not exaggeration of the market. The collateral reports above the debtor balances in CRVO and Olympus support part of the asset value — but judicial recovery is slow and uncertain.
The destitution assembly is the trigger that can change everything, both sides. Trade BREI with IGUANA in the middle of the execution of CRVO risks paralyzing the most important negotiation of the fund. Accompanying the call and the AGE quorum is mandatory for those in position — the result defines whether the IBCR11 follows with operational continuity or enters a risky transition.
Braspark is the bright side of the story, but conditional. The 12x discharge from August strengthens the cash and shortens the term — provided the secondary of the GGRC11 absorbs the sales flow. It's an improvement to confirm month by month, not a fait accompli.
What to observe: the date and result of the destitution AGE; the progress of the execution of the CRVO; the fulfillment of the first portions of the Braspark from Aug/26; and any sign on the Olympus. For the advanced investor who already carries the position, maintain and monitor. For those who are outside, disagreement is tempting, but the risk of governance added to the two defaults calls for caution — it is not the time for beginners to enter.
